Maxcyte, INC. (MXCT) SEC Filings — 2025
15 SEC filings for Maxcyte, INC. (MXCT) in 2025.
Filings
- MaxCyte Revenue Plunges 16% Amid Widening Losses, Cash Burn Accelerates — 10-Q · Nov 13, 2025
- Maxcyte, INC. 8-K Filing — 8-K · Nov 12, 2025
- MaxCyte, Inc. Files 8-K on Financials — 8-K · Nov 5, 2025
- MaxCyte Files 8-K on Exit Costs and Disclosures — 8-K · Sep 22, 2025
- MaxCyte, Inc. Reports Leadership Changes and Compensation Details — 8-K · Aug 11, 2025
- MaxCyte's Q2 Loss Widens Amidst Revenue Dip — 10-Q · Aug 6, 2025
- MaxCyte, Inc. Files 8-K Report — 8-K · Jun 25, 2025
- MaxCyte Licenses Flow Electroporation Tech to Pharma Giant — 8-K · Jun 18, 2025
- MaxCyte Files 2025 Proxy Statement — DEFA14A · May 29, 2025
- MaxCyte, Inc. Files Q1 2025 10-Q — 10-Q · May 8, 2025
- MaxCyte Files 8-K on Operations and Financials — 8-K · May 7, 2025
- MaxCyte Files Definitive Proxy Statement for 2025 Shareholder Meeting — DEF 14A · Apr 28, 2025
- MaxCyte, Inc. Files 2024 10-K — 10-K · Mar 11, 2025
- MaxCyte, Inc. Files 8-K for Financials and Reg FD — 8-K · Jan 30, 2025
- MaxCyte, Inc. Files 8-K on Financials — 8-K · Jan 13, 2025